ALBT - Avalon GloboCare Corp.
0.9169
0.050 5.442%
Share volume: 563,543
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$0.87
0.05
0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-30-2024 | 08-19-2024 | 11-12-2024 | 05-13-2025 | 08-14-2025 | 11-14-2025 | |
| Assets | |||||||
| Total Assets | 20.333 M | 19.516 M | 19.551 M | 10.610 M | 7.988 M | 9.128 M | |
| Current Assets | 777.817 K | 712.881 K | 1.397 M | 2.794 M | 933.088 K | 2.089 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 305.468 K | 200.572 K | 1.024 M | 1.370 M | 201.532 K | 333.931 K | |
| Total Non-current Assets | 12.042 M | 11.400 M | 10.813 M | 675.000 K | 0.000 | 0.000 | |
| Property Plant Equipment | 35.735 K | 33.418 K | 31.163 K | 10.660 K | 8.512 K | 6.355 K | |
| Other Assets | 19.520 M | 18.770 M | 18.123 M | 7.805 M | 7.047 M | 8.062 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 20.333 M | 19.516 M | 19.551 M | 10.610 M | 7.988 M | 9.128 M | |
| Total liabilities | 14.279 M | 15.099 M | 14.149 M | 14.501 M | 15.100 M | 13.621 M | |
| Total current liabilities | 7.803 M | 8.593 M | 12.332 M | 14.449 M | 15.065 M | 13.604 M | |
| Accounts Payable | 1.104 M | 1.172 M | 1.274 M | 624.872 K | 406.077 K | 301.067 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 51.706 K | 35.022 K | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 6.476 M | 6.506 M | 1.817 M | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 51.706 K | 35.022 K | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -13.946 M | -15.583 M | -14.599 M | -16.235 M | -19.456 M | -17.121 M | |
| Common stock | 67.942 M | 68.434 M | 71.095 M | 74.674 M | 84.912 M | 87.495 M | |
| Retained earnings | -81.137 M | -83.269 M | -84.948 M | -90.155 M | -103.614 M | -103.868 M |